The past few years have witnessed an emergent growth of both academic and practical works on English medium instruction (EMI) teachers' professional development. This paper presents a critical analysis of 30 empirical studies on EMI teacher development in a wide range of higher educational settings from 2018 to 2022. Through a systematic process of paper selection and review, we have identified three general routes to EMI teacher development, namely: (1) formal training activities; (2) opportunities for teacher collaboration; and (3) self-initiated practices. For each route, we presented a critical appraisal of their design and implementation, as well as reported gains and challenges. Meanwhile, we also conducted a critical analysis of the methodological issues pertaining to the selected papers. Overall, we argue that EMI teacher development in higher education is largely construed as a hybrid, contested, and transformative enterprise featured by EMI teachers' constant boundary-crossing at different levels to seek professional growth in linguistic, pedagogical, cultural, and psychological domains. During this process, EMI teachers may encounter conflicted dispositions, power asymmetries, and individual contradictions. Such a process thus requires EMI teachers to rethink, reexamine, and reflect critically on their accustomed preconceptions and practices, in order to facilitate transformation and achieve sustainability in the long run. The review also presents implications for EMI teachers, teacher educators, policymakers, and researchers on effectively facilitating EMI teacher development in higher education.

Although the criteria that support reimbursement decisions for medicines are often set by legislation, as is the case in Spain, in many cases neither the definition nor the measurement methods for these criteria are provided. Our goal was to elicit the views of a large sample of Spanish technical specialists on how to evaluate each one of the criteria that inform pricing and reimbursement decisions in Spain. Professionals from various stakeholder groups involved in health economics, health technology assessment, and industry participated in a survey. Participants recommended that reimbursement decisions should take specific account of unmet medical need and rare diseases. Health benefit should be measured using quality-adjusted life-years. There should be an explicit cost-effectiveness threshold, and this threshold should take account of population groups and special situations.

‘De-risking’ is the latest buzzword in the China strategy of the United States and its allies. It means limiting dependence on and engagement with China in select strategic sectors. One of such sectors concerns critical minerals (CMs) which are essential for the ongoing green economic transition. To secure access to CMs and reduce reliance on China, the US and its allies have been developing networks for ally-shoring supply chains. A major problem with the ‘de-risking’ strategy in this regard is that it treats China as the risk and hence excludes China from the discussions and collaboration on global supply chain issues. In this paper, we argue that this strategy fails to consider China's strategies and policies regarding CMs. We therefore offer a detailed analysis of China's policies which shows that they have been primarily aimed at addressing internal challenges and policy priorities in China rather than dominating, weaponizing, or causing disruptions in global supply chains. To address supply chain risks most effectively, international collaborative frameworks should engage with, rather than exclude, China. Confrontational strategies with ‘China being the risk’ at the core might themselves be a risk by undermining rational policymaking and leading to disruptive policies.

In his 2019 essay, Arthur Kleinman laments that medicine has become ever-competent at managing illness, yet caring for those who are ill is increasingly out of practice. He opines that the language of ‘the soul’ is helpful to those practicing medicine, as it provides an important counterbalance to medicine’s technical rationality that avoids the existential and spiritual domains of human life. His accusation that medicine has become soulless merits considering, yet we believe his is the wrong description of contemporary medicine. Where medicine is disciplined by technological and informational rationalities that risk coercing attention away from corporealities and toward an impersonal, digital order, the resulting practices expose medicine to becoming not soulless but excarnated. Here we engage Kleinman in conversation with Franco Berardi, Charles Taylor, and others to ask: Have we left behind the body for senseless purposes? Perhaps medicine is not proving itself to be soulless, but rather senseless, bodyless – the any-occupation of excarnated souls. If so, the dissension of excarnation and the recovery of touching purpose seems to us to be an apparent need within the contemporary and increasingly digitally managed and informationally ordered medical milieu.

With the recent passage of the Carbon Border Adjustment Mechanism (CBAM), the free allocation of emission permits under the EU Emissions Trading System (EU ETS) that currently acts as a safeguard against emissions leakage and industrial relocation will progressively be phased out. Because the CBAM only covers imports, however, European goods exported into global markets stand to become more vulnerable to emissions leakage. Different policy options have been discussed to counter such export-related leakage, but they variously face concerns regarding their environmental, political, and legal implications. We describe and evaluate the three most important policy options based on their potential to reduce export-related leakage, support the net-zero transformation in Europe as well as globally, ensure conformity with international trade law, secure administrative feasibility, and foster political acceptance by affected trade partners. While no single option outperforms its alternatives on all criteria, our analysis identifies targeted innovation support as a promising option because it minimizes legal and political risks while also offering climate benefits beyond leakage protection for European industry. We then discuss the sectors that are most likely to require innovation support, the policy instruments that could serve to operationalize such support, and potential funding sources. We conclude with guiding principles for technology support measures, reflecting on the implications of the current surge in industrial policy within Europe and beyond.

Phosphorus (P) is a non-renewable resource that limits plant productivity due to its low bioavailability in the soil. Large amounts of P fertilizer are required to sustain high yields, which is both inefficient and hazardous to the environment. Plants have evolved various adaptive responses to cope with low external P availability, including mobilizing cellular P through phosphate (Pi) transporters and recycling Pi from P-containing biomolecules to maintain cellular P homeostasis. This mini-review summarizes the current research on intracellular P recycling and mobilization in response to P availability. We introduce the roles of Pi transporters and the P metabolic enzymes and expand on their gene regulation and mechanisms. The relevance of these processes in the search for targets to improve phosphorus use efficiency and some of the current challenges and gaps in our understanding of P starvation responses are discussed.

The amphipod Ampithoe bizseli Özaydinli and Coleman, 2012 is a cryptogenic species that was recently described in Turkey. Although to date it has only been recorded in the Mediterranean Basin, it is potentially native to the Red Sea and Indian Ocean. During a macrozoobenthos sampling campaign carried out in the Canary Islands in 2023, 25 individuals of A. bizseli were found in association with some fish farm facilities. This work represents the first report of this amphipod in European Atlantic waters and increases knowledge of the ecology of this non-indigenous species.